Results 231 to 240 of about 34,901 (267)

In vivo development of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae infections: a case series. [PDF]

Eur J Clin Microbiol Infect Dis
Boattini M, Bianco G, Comini S, Costa C, Gaibani P.   +4 more
europepmc   +1 more source

In-vitro activity of the novel β-lactam/β-lactamase inhibitor combinations and cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates collected in Switzerland in 2022. [PDF]

Eur J Clin Microbiol Infect Dis
Le Terrier C, Bouvier M, Kerbol A, Dell'Acqua C, Nara Network members, Nordmann P, Poirel L.   +6 more
europepmc   +1 more source

Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa. [PDF]

J Antimicrob Chemother
González-Pinto L, Alonso-García I, Blanco-Martín T, Camacho-Zamora P, Fraile-Ribot PA, Outeda-García M, Lasarte-Monterrubio C, Guijarro-Sánchez P, Maceiras R, Moya B, Juan C, Vázquez-Ucha JC, Beceiro A, Oliver A, Bou G, Arca-Suárez J.   +15 more
europepmc   +1 more source

Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamases. [PDF]

Antimicrob Agents Chemother
Le Terrier C, Viguier C, Nordmann P, Vila AJ, Poirel L.   +4 more
europepmc   +1 more source

Activity of cefepime, carbapenems and new β-lactam/β-lactamase inhibitor combinations on Enterobacter cloacae complex and Klebsiella aerogenes in Spain (SMART 2016-2022). [PDF]

JAC Antimicrob Resist
Rodríguez-Villodres Á, Lepe-Balsalobre E, Ortiz De La Rosa JM, Giner Almaraz S, González De Herrero E, Cercenado E, García-Fernández S, Benito R, Ponz Mir R, Cantón R, Lepe JA.   +10 more
europepmc   +1 more source

In vivo dose response and efficacy of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against the Acinetobacter baumannii-calcoaceticus complex. [PDF]

Antimicrob Agents Chemother
O'Donnell J, Tanudra A, Chen A, Newman J, McLeod SM, Tommasi R.   +5 more
europepmc   +1 more source

Structure Guided Discovery of Novel Pan Metallo-β-Lactamase Inhibitors with Improved Gram-Negative Bacterial Cell Penetration

Shuzhi Dong, Zhiqiang Zhao, Haiqun Tang, Guoqing Li, Jianping Pan, Xin Gu, Jinlong Jiang, Xiao Li, Giovanna Scapin, David N. Hunter, Dexi Yang, Yuhua Huang, Frank Bennett, Shu‐Wei Yang, Mihirbaran Mandal, Haifeng Tang, Jing Su, Clare Tudge, Reynalda deJesus, Fa‐Xiang Ding, Matthew Lombardo, Jacqueline D. Hicks, Thierry Fischmann, Asra Mirza, Priya Dayananth, Ronald E. Painter, Artjohn Villafania, Charles G. Garlisi, Rumin Zhang, Todd Mayhood, Qian Si, Nianyu Li, Rupesh P. Amin, Bhavana Bhatt, Feifei Chen, Christopher P. Regan, Hillary Regan, Xinjie Lin, Jin Wu, Andrew Leithead, Scott R. Pollack, Jack D. Scott, Ravi P. Nargund, Alex G. Therien, Todd A. Black, Katherine Young, Alexander Pasternak   +46 more
openalex   +1 more source

ARGONAUT-III and -V: susceptibility of carbapenem-resistant <i>Klebsiella pneumoniae</i> and multidrug-resistant <i>Pseudomonas aeruginosa</i> to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime. [PDF]

Antimicrob Agents Chemother
Jacobs MR, Abdelhamed AM, Good CE, Mack AR, Bethel CR, Marshall S, Hujer AM, Hujer KM, Patel R, van Duin D, Fowler VG, Rhoads DD, Six DA, Moeck G, Uehara T, Papp-Wallace KM, Bonomo RA.   +16 more
europepmc   +1 more source